Sales decline 12.92% to Rs 15.77 crore
Net profit of Indo US Bio-Tech declined 81.23% to Rs 0.52 crore in the quarter ended March 2024 as against Rs 2.77 crore during the previous quarter ended March 2023. Sales declined 12.92% to Rs 15.77 crore in the quarter ended March 2024 as against Rs 18.11 crore during the previous quarter ended March 2023.For the full year,net profit rose 13.95% to Rs 8.25 crore in the year ended March 2024 as against Rs 7.24 crore during the previous year ended March 2023. Sales rose 17.98% to Rs 72.84 crore in the year ended March 2024 as against Rs 61.74 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales15.7718.11 -13 72.8461.74 18 OPM %6.2117.06 -14.8315.19 - PBDT0.832.84 -71 9.618.22 17 PBT0.632.63 -76 8.817.39 19 NP0.522.77 -81 8.257.24 14
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
